Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

5

Number of overlapping holdings

21.7%

% of THNR's 23 holdings also in MEDX

16.7%

% of MEDX's 30 holdings also in THNR

Overlap by Weight
Sector Drift (THNR minus MEDX)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in THNR
Weight
in MEDX
Overlap
ELI LILLY & CO 17.3% 18.6% 17.3%
AMGEN INC 4.9% 6.2% 4.9%
ASTRAZENECA PLC-SPONS ADR 4.9% 5.6% 4.9%
PFIZER INC 4.8% 3.8% 3.8%
MERCK & CO. INC. 4.5% 3.5% 3.5%

Position Highlights (Non-Overlapping Exposures)
THNR Overweight Relative to MEDX
NOVO-NORDISK A/S-SPONS ADR 12.6%
CHUGAI PHARMACEUTICAL CO LTD 6.1%
INNOVENT BIOLOGICS, INC. 5.5%
ROCHE HOLDING LTD 5.0%
WEST PHARMACEUTICAL SERVICES 5.0%
THERMO FISHER SCIENTIFIC INC 4.7%
TEVA PHARMACEUTICAL-SP ADR 4.6%
HIMS & HERS HEALTH, INC. CLASS A 3.7%
MITSUBISHI CHEMICAL HOLDINGS 3.5%
ZEALAND PHARMA A/S 2.4%
THNR Underweight Relative to MEDX
ABBVIE INC -8.8%
NOVARTIS AG-ADR -7.0%
BRISTOL-MYERS SQUIBB CO -5.8%
JOHNSON & JOHNSON -5.3%
ALNYLAM PHARMACEUTICALS INC -4.5%
ALKERMES PLC -4.1%
REGENERON PHARMACEUTICALS -2.7%
GLAXOSMITHKLINE PLC-SPON ADR -2.7%
CRISPR THERAPEUTICS AG -2.6%
BIOGEN IDEC INC -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY